Anesthesia for liver transplant surgery

Anesthesiology Clinics of North America

Volumn 22, Issue 4, 2004, Pages 687-711

  Steadman, Randolph H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; CISATRACURIUM; CYCLOSPORIN; DIURETIC AGENT; FENTANYL; HALOTHANE; ISOFLURANE; KALLIKREIN; LIDOCAINE; MIDAZOLAM; OPIATE; PANCURONIUM; PROPRANOLOL DERIVATIVE; REMIFENTANIL; TERLIPRESSIN; TRANEXAMIC ACID; VASOCONSTRICTOR AGENT; VASODILATOR AGENT; VASOPRESSIN DERIVATIVE;

AGE DISTRIBUTION; ANESTHESIA; ARTERY OCCLUSION; ASCITES; BILIARY TRACT DRAINAGE; BLEEDING; CADAVER; CLINICAL TRIAL; DRUG MECHANISM; DRUG METABOLISM; DRUG SENSITIVITY; FIBRINOLYSIS; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER TRANSPLANTATION; LUNG EMBOLISM; MORBIDITY; MORTALITY; NONHUMAN; OUTCOMES RESEARCH; PARACENTESIS; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; RECIPIENT; REVIEW; RIGHT CORONARY ARTERY; SIDE EFFECT; SURVIVAL RATE; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANESTHESIA; CADAVER; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONORS; MONITORING, INTRAOPERATIVE; PATIENT SELECTION; REOPERATION;

EID: 8444242134     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2004.06.009     Document Type: Review

References (116)

1. G. Fattovich, G. Giustina, F. Degos, F. Tremolada, G. Diodati, and P. Almasio Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients Gastroenterology 112 1997 463 472
2. N. Chalasani, C. Kahi, F. Francois, A. Pinto, A. Marathe, and E.J. Bini Improved patient survival after acute variceal bleeding: a multicenter, cohort study Am J Gastroenterol 98 3 2003 653 659
3. T.E. Starzl Homotransplantation of the liver in humans Surg Gynecol Obstet 117 1963 659 676
4. T.E. Starzl, S. Todo, J. Fung, A.J. Demetris, R. Venkataramman, and A. Jain FK 506 for liver, kidney, and pancreas transplantation Lancet 2 8670 1989 1000 1004
5. R.L. Kirkman, M.E. Shapiro, C.B. Carpenter, D.B. McKay, E.L. Milford, and E.L. Ramos A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation Transplantation 51 1 1991 107 113
6. CDC and the National Center for Injury Prevention and Control Web-based injury statistics query and reporting system Available at: http://www.cdc.gov/ ncipc/wisqars/ Accessed: February 16, 2004
7. Organ Procurement US. and Transplantation Network Annual report of the US Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant data 1992-2001 Available at: http://www.optn.org/data/annualReport.asp Accessed: February 16, 2004
8. R. Carithers Liver transplantation Liver Transpl 6 1 2000 122 135
9. M Alter Epidemiology of hepatitis C Hepatology 26 Suppl 1 1997 62S 65S
10. E.C. Seaberg, S.H. Belle, K.C. Beringer, J.L. Schivins, and K.M. Detre Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS liver transplant registry J.M. Cecka Clinical transplants 1998 UCLA Tissue Typing Laboratory Los Angeles 17 37
11. P.G. Stock, L. Carlson, C.E. Freise, J.P. Roberts, R. Hirose, and N.A. Terrault Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study Transplantation 76 2 2003 370 375
12. M.E. Roland, and P.G. Stock Review of solid-organ transplantation in HIV-infected patients Transplantation 75 4 2003 425 429
13. R.J. Ede, and R.W. Williams Hepatic encephalopathy and cerebral edema Semin Liver Dis 6 2 1986 107 118
14. J.P. Donovan, D.F. Schafer, B.W. Shaw Jr., and M.F. Sorrell Cerebral oedema and increased intracranial pressure in chronic liver disease Lancet 351 9104 1998 719 721
15. J.S. Crippin, J.B. Gross Jr., and K.D. Lindor Increased intracranial pressure and hepatic encephalopathy in chronic liver disease Am J Gastroenterol 87 7 1992 879 882
16. S.D. Colquhoun, C. Lipkin, and C.A. Connelly The pathophysiology, diagnosis, and management of acute hepatic encephalopathy Adv Intern Med 46 2001 155 176
17. J. Cordoba Glutamine, myo-inositol, and brain edema in acute liver failure Hepatology 23 5 1996 1291
18. D. Haussinger, G. Kircheis, R. Fischer, F. Schliess, and S. vom Dahl Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? Hepatology 32 2000 1035 1038
19. B.J. Ruscito, and N.L. Harrison Hemoglobin metabolites mimic benzodiazepines and are possible mediators of hepatic encephalopathy Blood 102 4 2003 1525 1528
20. F. Glauser Systemic hemodynamic and cardiac function changes in patients undergoing orthotopic liver transplantation Chest 98 5 1990 1210
21. S. Batkai, Z. Jarai, J.A. Wagner, S.K. Goparaju, K. Varga, and J. Liu Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis Nat Med 7 7 2001 827 832
22. P. Harrison, J. Wendon, and R. Williams Evidence of increased guanylate cyclase activation by acetylcysteine in fulminant hepatic failure Hepatology 23 5 1996 1067 1072
23. W.D. Carey, R.R. Pimentel, D.S. Barnes, R.E. Hobbs, J.M. Henderson, and D.P. Vogt The prevalence of coronary artery disease in liver transplant candidates over age 50 Transplantation 59 6 1995 859 864
24. J.S. Plotkin, L.B. Johnson, V. Rustgi, and P.C. Kuo Coronary artery disease and liver transplantation: the state of the art Liver Transpl 6 Suppl 1 2000 S53 S56
25. C.L. Donovan, P.A. Marcovitz, J.D. Punch, D.S. Bach, K.A. Brown, and M.R. Lucey Two-dimensional and dobutamine stress echocardiography in the preoperative assessment of patients with end-stage liver disease prior to orthotopic liver transplantation Transplantation 61 8 1996 1180 1188
26. C.L. Cotton, P.T. Vaitkus, M.G. Massad, E. Benedetti, R.G. Mrtek, and T.E. Wiley Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates Liver Transpl 8 11 2002 1051 1054
27. J.S. Plotkin, V.L. Scott, A. Pinna, B.P. Dobsch, A.M. De Wolf, and Y. Kang Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation Liver Transpl Surg 2 6 1996 426 430
28. M.J. Krowka, A.J. Tajik, E.R. Dickson, R.H. Wiesner, and D.A. Cortese Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography Chest 97 5 1990 1165 1170
29. L.S. Eriksson Hypoxemia in patients with liver cirrhosis Acta Gastroenterol Belg 53 2 1990 209 215
30. E.A. Collisson, M.H. Fraiman, C.B. Cooper, P.E. Bellamy, D.G. Farmer, and J.M. Vierling Retrospective analysis of the results of liver transplantation for adults with severe hepatopulmonary syndrome Liver Transpl 8 10 2002 925 931
31. D. Plevak, M. Krowka, S. Rettke, W. Dunn, and P. Southorn Successful liver transplantation in patients with mild to moderate pulmonary hypertension Transplant Proc 25 2 Apr 1993 1840
32. M.J. Krowka, D.J. Plevak, J.Y. Findlay, C.B. Rosen, R.H. Wiesner, and R.A. Krom Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation Liver Transpl 6 4 2000 443 450
33. M.J. Krowka, M.S. Mandell, M.A. Ramsay, S.M. Kawut, M.B. Fallon, and C. Manzarbeitia Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database Liver Transpl 10 2 2004 174 182
34. H. Tan Liver transplantation in patients with severe portopulmonary hypertension treated with preoperative chronic intravenous epoprostenol Liver Transpl 7 8 2001 745 749
35. M.J. Krowka Pulmonary hypertension, (high) risk of orthotopic liver transplantation, and some lessons from "primary" pulmonary hypertension [editorial] Liver Transpl 8 4 2002 389 390
36. C.L. Davis Identification of patients best suited for combined liver-kidney transplantation. Part II Liver Transpl 8 3 2002 193 211
37. A. Cardenas, J. Uriz, P. Gines, and V. Arroyo Hepatorenal syndrome Liver Transpl 6 Suppl 1 2000 S63 S71
38. K. Moore, J. Wendon, M. Frazer, J. Karani, R. Williams, and K. Badr Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome N Engl J Med 327 25 1992 1774 1778
39. J. Uriz, P. Gines, A. Cardenas, P. Sort, W. Jimenez, and J.M. Salmeron Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome J Hepatol 33 1 2000 43 48
40. P. Solanki, A. Chawla, R. Garg, R. Gupta, M. Jain, and S.K. Sarin Beneficial effects of terlipressin in hepatorenal syndrome: a prospective, randomized placebo-controlled clinical trial J Gastroenterol Hepatol 18 2 2003 152 156
41. L.A. D'Albuquerque, M.P. de Miranda, T. Genzini, J.L. Copstein, and A. de Oliveira e Silva Laparoscopic cholecystectomy in cirrhotic patients Surg Laparosc Endosc 5 4 1995 272 276
42. M.A. Ramsay The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation Liver Transpl Surg 3 6 1997 665 668
43. L. Amitrano, M.A. Guardascione, V. Brancaccio, and A. Balzano Coagulation disorders in liver disease Semin Liver Dis 22 1 2002 83 96
44. T. Kawasaki, A. Takeshita, K. Souda, Y. Kobayashi, M. Kikuyama, and F. Suzuki Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis Am J Gastroenterol 94 7 1999 1918 1922
45. S. Ingeberg, P. Jacobsen, E. Fischer, and K.D. Bentsen Platelet aggregation and release of ATP in patients with hepatic cirrhosis Scand J Gastroenterol 20 3 1985 285 288
46. M.H. Rubin, M.J. Weston, P.G. Langley, Y. White, and R. Williams Platelet function in chronic liver disease: relationship to disease severity Dig Dis Sci 24 3 1979 197 202
47. R.N. Pugh, I.M. Murray-Lyon, J.L. Dawson, M.C. Pietroni, and R. Williams Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 8 1973 646 649
48. F. Violi, D. Ferro, S. Basili, C. Quintarelli, A. Musca, C. Cordova for the CALC Group Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. Coagulation abnormalities in liver cirrhosis Hepatology 17 1 1993 78 83
49. J.H. Joist AICF and DIC in liver cirrhosis: expressions of a hypercoagulable state Am J Gastroenterol 94 10 1999 2801 2803
50. I. Tegeder, J. Lotsch, and G. Geisslinger Pharmacokinetics of opioids in liver disease Clin Pharmacokinet 37 1 1999 17 40
51. R.H. Wiesner, S.V. McDiarmid, P.S. Kamath, E.B. Edwards, M. Malinchoc, and W.K. Kremers MELD and PELD: application of survival models to liver allocation Liver Transpl Jul 7 7 2001 567 580
52. C.G. Child Surgery and portal hypertension C.G. Child The liver and portal hypertension 1964 WB Saunders Philadelphia 50 58
53. R.B. Freeman Jr. In pursuit of the ideal liver allocation model Liver Transpl 8 9 2002 799 801
54. R.B. Freeman Jr., and E.B. Edwards Liver transplant waiting time does not correlate with waiting list mortality: implications for liver allocation policy Liver Transpl 6 5 2000 543 552
55. P.S. Kamath, R.H. Wiesner, M. Malinchoc, W. Kremers, T.M. Therneau, and C.L. Kosberg A model to predict survival in patients with end-stage liver disease Hepatology 33 2 2001 464 470
56. J. O'Riordan, H.A. O'Beirne, Y. Young, and M.C. Bellamy Effects of desflurane and isoflurane on splanchnic microcirculation during major surgery Br J Anaesth 78 1 1997 95 96
57. C. Gatecel, M.R. Losser, and D. Payen The postoperative effects of halothane versus isoflurane on hepatic artery and portal vein blood flow in humans Anesth Analg 96 3 2003 740 745
58. K. Armbruster, G.F. Noldge-Schomburg, I.M. Dressler, A.J. Fittkau, J. Haberstroh, and K. Geiger The effects of desflurane on splanchnic hemodynamics and oxygenation in the anesthetized pig Anesth Analg 84 2 1997 271 277
59. S.W. Suttner, C.C. Schmidt, J. Boldt, I. Huttner, B. Kumle, and S.N. Piper Low-flow desflurane and sevoflurane anesthesia minimally affect hepatic integrity and function in elderly patients Anesth Analg 91 1 2000 206 212
60. E.J. Frink Jr. The hepatic effects of sevoflurane Anesth Analg 81 Suppl 6 1995 S46 S50
61. E.D. Kharasch, E.J. Frink Jr., A. Artru, P. Michalowski, G.A. Rooke, and W. Nogami Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function Anesth Analg 93 6 2001 1511 1520
62. A.M. De Wolf, J.A. Freeman, V.L. Scott, W. Tullock, D.A. Smith, and D.F. Kisor Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation Br J Anaesth 76 5 1996 624 628
63. R.J. Marcel, M.A. Ramsay, H.A. Hein, A.T. Nguyen, K.J. Ramsay, and C.T. Suit Duration of rocuronium-induced neuromuscular block during liver transplantation: a predictor of primary allograft function Anesth Analg 84 4 1997 870 874
64. J. Dupont, F. Messiant, N. Declerck, B. Tavernler, B. Jude, and L. Durihck Liver transplantation without the use of fresh frozen plasma Anesth Analg 83 4 1996 681 686
65. Y. Kang Transfusion based on clinical coagulation monitoring does reduce hemorrhage during liver transplantation Liver Transpl Surg 3 6 1997 655 659
66. M. Reyle-Hahn, and R. Rossaint Coagulation techniques are not important in directing blood product transfusion during liver transplantation Liver Transpl Surg 3 6 1997 659 663 [discussion p. 663-5]
67. Y. Ozier, F. Pessione, E. Samain, and F. Courtois Institutional variability in transfusion practice for liver transplantation Anesth Analg 97 3 2003 671 679
68. Z.K. Wszolek, R.D. McComb, R.F. Pfeiffer, R.E. Steg, R.P. Wood, and B.W. Shaw Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium Transplantation 48 6 1989 1006 1012
69. V.L. Scott, A.M. De Wolf, Y. Kang, B.T. Altura, M.A. Virji, and D.R. Cook Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: a complication of citrate intoxication Liver Transpl Surg 2 5 1996 343 347
70. T. Swygert Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients Anesthesiology 75 4 1991 571 576
71. E.B. Haagsma, C.H. Gips, H. Wesenhagen, G.W. Van Imhoff, and R.A. Krom Liver disease and its effect on haemostasis during liver transplantation Liver 5 3 1985 123 128
72. W.O. Bechstein, and P. Neuhaus Bleeding problems in liver surgery and liver transplantation Chirurg 71 4 2000 363 368
73. G. Rossi Veno-venous bypass versus no bypass in orthotopic liver transplantation: hemodynamic, metabolic, and renal data Transplant Proc 30 1998 1871 1873
74. M.C. Prager, G.A. Gregory, N.L. Ascher, and J.P. Roberts Massive venous air embolism during orthotopic liver transplantation Anesthesiology 72 1 1990 198 200
75. R.Y. Calne, K. Rolles, J.V. Farman, J.D. Kneeshaw, D.P. Smith, and D.R. Wheeldon Veno-arterial bypass in orthotopic liver grafting Lancet 2 8414 1984 1269
76. B.W. Shaw Jr., D.J. Martin, J.M. Marquez, Y.G. Kang, A.C. Bugbec Jr, and S. Iwatsuki Venous bypass in clinical liver transplantation Ann Surg 200 4 1984 524 534
77. A. Tzakis, S. Todo, and T.E. Starzl Orthotopic liver transplantation with preservation of the inferior vena cava Ann Surg 210 5 1989 649 652
78. G.B. Bulkley Reactive oxygen metabolites and reperfusion injury: aberrant triggering of reticuloendothelial function Lancet 344 8927 1994 934 936
79. A.K. Chui, L. Shi, K. Tanaka, A.R. Rao, L.S. Wang, and M. Bookallil Postreperfusion syndrome in orthotopic liver transplantation Transplant Proc 32 7 2000 2116 2117
80. R.P. Kufner Antifibrinolytics do not reduce transfusion requirements in patients undergoing orthotopic liver transplantation Liver Transpl Surg 3 6 1997 668 674 [discussion 674-6]
81. J.Y. Findlay, S.R. Rettke, M.H. Ereth, D.J. Plevak, R.A. Krom, and R.P. Kufner Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study Liver Transpl 7 9 2001 802 807
82. R.J. Porte, I.Q. Molenaar, B. Begliomini, T.H. Groenland, A. Januszkiewicz, L. Lindgren for the EMSALT Study Group Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study Lancet 355 9212 2000 1303 1309
83. W.O. Bechstein, and P. Neuhaus A surgeon's perspective on the management of coagulation disorders before liver transplantation Liver Transpl Surg 3 6 1997 653 655
84. C.J. O'Connor, D. Roozeboom, R. Brown, and K.J. Tuman Pulmonary thromboembolism during liver transplantation: possible association with antifibrinolytic drugs and novel treatment options Anesth Analg 91 2 2000 296 299
85. J.F. Markmann, J.S. Markowitz, H. Yersiz, M. Morrisey, D.G. Farmer, and D.A. Farmer Long-term survival after retransplantation of the liver Ann Surg 226 4 1997 408 418 [discussion: 418-20]
86. G.B. Hammer, and E.J. Krane Anaesthesia for liver transplantation in children Paediatr Anaesth 11 1 2001 3 18
87. W. Lee Management of acute liver failure Semin Liver Dis 16 4 1996 369
88. A. Ellis, and J. Wendon Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management Semin Liver Dis 16 4 1996 379 388
89. P.N. Bromley, S.J. Cottam, I. Hilmi, K.C. Tan, N. Heaton, and R. Ginsburg Effects of intraoperative N-acetylcysteine in orthotopic liver transplantation Br J Anaesth 75 3 1995 352 354
90. J.G. O'Grady, G.J. Alexander, K.M. Hayllar, and R. Williams Early indicators of prognosis in fulminant hepatic failure Gastroenterology 97 2 1989 439 445
91. A.C. Anand, P. Nightingale, and P. Neuberger Early indicators of prognosis in fulminant hepatic failure: an assessment of the King's criteria J Hepatol 26 1997 62 68
92. A.O.K. Shakil, D. Mazariegos, G.V. Fung, and J.J. Rakela Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria Liver Transpl 6 2 2000 163 169
93. G. Ostapowicz, R.J. Fontana, F.V. Schiodt, A. Larson, T.J. Davern, and S.H. Han Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States Ann Intern Med 137 2002 947 954
94. A.T. Blei, S. Olafsson, S. Webster, and R. Levy Complications of intracranial pressure monitoring in fulminant hepatic failure Lancet 341 8838 1993 157 158
95. M.R. Bullock, and G.L. Clifton Management and prognosis of severe traumatic brain injury Available at: http://www2.braintrauma.org/guidelines Accessed February 23, 2004
96. S.S. Awad, J. Magee, J. Punch, and R.H. Bartlett Results of a phase I trial evaluating a liver support device utilizing albumin dialysis Surgery 130 2 2001 354 362
97. S.R. Mitzner, J. Stange, S. Klammt, T. Risler, C.M. Erley, and B.D. Bader Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial Liver Transpl 6 3 2000 277 286
98. J.G. O'Grady, A.E. Gimson, C.J. O'Brien, A. Pucknell, R.D. Hughes, and R. Williams Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure Gastroenterology 94 1988 1186 1192
99. J. Rozga, L. Podesta, E. LePage, E. Morsiani, A.D. Moscioni, and A. Hoffman A bioartificial liver to treat severe acute liver failure Ann Surg 219 5 1994 538 544 [discussion: 544-6]
100. F.D. Watanabe, and A.A. Demetriou Support of acute liver failure patients with a bioartificial liver J Clin Apheresis 11 3 1996 138 142
101. A.J. Ellis, R.D. Hughes, J.A. Wendon, J. Dunne, P.G. Langley, and J.H. Kelly Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure Hepatology 24 6 1996 1446 1451
102. A. Krasko Liver failure, transplantation, and critical care Crit Care Clin 19 2 2003 155 183
103. H. Bismuth, and D. Houssin Reduced-size ortotopic liver graft in hepatic transplantation in children Surgery 95 3 1984 367 370
104. R.W. Busuttil, and J.A. Goss Split liver transplantation Ann Surg 229 3 1999 313 321
105. D. Houssin, O. Soubrane, O. Boillot, B. Dousset, Y. Ozier, and D. Devictor Orthotopic liver transplantation with a reduced-size graft: an ideal compromise in pediatrics? Surgery 111 5 1992 532 542
106. R. Pichlmayr, B. Ringe, G. Gubernatis, J. Hauss, and H. Bunzendahl Transplantation of a donor liver to 2 recipients (splitting transplantation)-a new method in the further development of segmental liver transplantation Langenbecks Arch Chir 373 2 1988 127 130
107. J.F. Renz, J.C. Emond, H. Yersiz, N.L. Ascher, and R.W. Busuttil Split-liver transplantation in the United States: outcomes of a national survey Ann Surg 239 2 2004 172 181
108. M. Rela, P. Muiesan, H. Vilca-Melendez, V. Smyrniotis, P. Gibbs, and J. Karani Split liver transplantation: King's College Hospital experience Ann Surg 227 2 1998 282 288
109. A.N. Langnas, W.C. Marujo, M. Inagaki, R.J. Stratta, R.P. Wood, and B.W. Shaw Jr. The results of reduced-size liver transplantation, including split livers, in patients with end-stage liver disease Transplantation 53 2 1992 387 391
110. R.M. Ghobrial, S. Saab, C. Lassman, D.S. Lu, S. Raman, and P. Limanond Donor and recipient outcomes in right lobe adult living donor liver transplantation Liver Transpl 8 10 2002 901 909
111. Anonymous American Society of Transplant Surgeons' position paper on adult-to-adult living donor liver transplantation Liver Transpl 6 6 2000 815 817
112. N. Heaton Small-for-size liver syndrome after auxiliary and split liver transplantation: donor selection Liver Transpl 9(9) Suppl 2003 S26 S28
113. T. Kiuchi, M. Kasahara, K. Uryuhara, Y. Inomata, S. Uemoto, and K. Asonuma Impact of graft size mismatching on graft prognosis in liver transplantation from living donors Transplantation 67 2 1999 321 327
114. R.W. Strong Whither living donor liver transplantation? Liver Transpl 5 6 1999 536 538
115. O.S. Surman The ethics of partial-liver donation N Engl J Med 346 14 2002 1038
116. D.J. Dixon, and S.E. Abbey Transplantation of the right hepatic lobe [author's reply] N Engl J Med 347 8 2002 615 618